ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 59 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $298,000 | +380.6% | 846,808 | +167.1% | 0.00% | – |
Q1 2020 | $62,000 | +3.3% | 317,043 | +15.7% | 0.00% | – |
Q4 2019 | $60,000 | -4.8% | 274,065 | 0.0% | 0.00% | – |
Q3 2019 | $63,000 | -6.0% | 274,065 | 0.0% | 0.00% | – |
Q2 2019 | $67,000 | -49.2% | 274,065 | 0.0% | 0.00% | – |
Q1 2019 | $132,000 | +24.5% | 274,065 | 0.0% | 0.00% | – |
Q4 2018 | $106,000 | -47.8% | 274,065 | 0.0% | 0.00% | – |
Q3 2018 | $203,000 | +198.5% | 274,065 | +157.6% | 0.00% | – |
Q2 2018 | $68,000 | +74.4% | 106,388 | 0.0% | 0.00% | – |
Q1 2018 | $39,000 | -45.1% | 106,388 | 0.0% | 0.00% | – |
Q4 2017 | $71,000 | +16.4% | 106,388 | 0.0% | 0.00% | – |
Q3 2017 | $61,000 | -53.1% | 106,388 | 0.0% | 0.00% | – |
Q2 2017 | $130,000 | -19.3% | 106,388 | 0.0% | 0.00% | – |
Q1 2017 | $161,000 | +192.7% | 106,388 | +69.4% | 0.00% | – |
Q4 2016 | $55,000 | -32.1% | 62,800 | +4.8% | 0.00% | – |
Q3 2016 | $81,000 | -22.1% | 59,900 | +1.7% | 0.00% | – |
Q2 2016 | $104,000 | +14.3% | 58,900 | +29.2% | 0.00% | – |
Q1 2016 | $91,000 | -38.1% | 45,589 | 0.0% | 0.00% | – |
Q4 2015 | $147,000 | +81.5% | 45,589 | 0.0% | 0.00% | – |
Q3 2015 | $81,000 | -87.1% | 45,589 | -80.8% | 0.00% | – |
Q2 2015 | $629,000 | +13.3% | 237,358 | +5.7% | 0.00% | – |
Q1 2015 | $555,000 | -54.6% | 224,592 | +8.2% | 0.00% | – |
Q4 2014 | $1,222,000 | -9.8% | 207,568 | +2.7% | 0.00% | – |
Q3 2014 | $1,355,000 | +400.0% | 202,181 | +438.8% | 0.00% | – |
Q2 2014 | $271,000 | – | 37,522 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|